Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Regenicin, Inc. (OTC: RGIN).

Full DD Report for RGIN

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-140.0205150.0205150.0205150.02051524,040
2018-12-130.0212350.0206350.0212350.02063530,000
2018-12-120.020.020.020.021,100
2018-12-110.0170.019250.01950.01762,000
2018-12-100.01850.01790.019950.017928,895

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1424,04024,040100.0000Short
2018-12-1320,00030,00066.6667Short
2018-12-1112,00062,00019.3548Cover
2018-12-0420,95366,81631.3593Cover
2018-12-039,00025,51035.2803Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on RGIN.


About Regenicin, Inc. (OTC: RGIN)

Logo for Regenicin, Inc. (OTC: RGIN)

Regenicin, Inc. is a development stage company focusing on next generation tissue engineered skin substitutes to restore the qualities of healthy human skin. It is devoted to the discovery, development, manufacture and marketing of innovative, high technology therapies and products for the wound care, tissue regeneration and therapeutic support system markets with PermaDerm the only tissue engineered skin prepared from a patient s own skin cells. Company is headquartered in Little Falls, NJ.

 

Contact Information

 

 

Current Management

  • Randall McCoy / CEO
  • John J. Weber / Interim CFO
  • Chris Hadsall / COO
  • Randall McCoy / Chairman
  • Craig Eagle /
  • John J. Weber /

Current Share Structure

  • Market Cap: $7,688,498 - 03/15/2018
  • Authorized: 200,000,000 - 02/28/2018
  • Issue and Outstanding: 153,769,968 - 02/28/2018

 


Recent Filings from (OTC: RGIN)

Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: May, 15 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 20 2018
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: February, 14 2018
Amendment to a previously filed 10-K
Filing Type: 10-K/AFiling Source: edgar
Filing Date: January, 23 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: January, 16 2018
Notification that form 10-K will be submitted late
Filing Type: NT 10-KFiling Source: edgar
Filing Date: December, 29 2017

 

 


Daily Technical Chart for (OTC: RGIN)

Daily Technical Chart for (OTC: RGIN)


Stay tuned for daily updates and more on (OTC: RGIN)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: RGIN)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in RGIN is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of RGIN and does not buy, sell, or trade any shares of RGIN. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/